Yuhan said on the 30th that it posted consolidation sales of 526.8 billion won and operating profit of 8.8 billion won in the first quarter of this year. They rose 7% and 37%, respectively, from a year earlier.
The pharmaceuticals division recorded sales of 348.9 billion won. Over-the-counter drugs (58.2 billion won) and prescription drugs (290.7 billion won) both grew evenly. In addition, the overseas division posted 106 billion won, and the healthcare division posted 48.1 billion won in sales.
A company official said, "Results in pharmaceuticals and healthcare both increased," adding, "The overseas business based on active pharmaceutical ingredients grew more than 20%, pushing quarterly sales past 100 billion won."
※ This article has been translated by AI. Share your feedback here.